These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 18936712

  • 1. Long-term clinical outcome of helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma is comparable to that of h. pylori-positive lymphoma.
    Chung SJ, Kim JS, Kim H, Kim SG, Kim CW, Jung HC, Song IS.
    J Clin Gastroenterol; 2009 Apr; 43(4):312-7. PubMed ID: 18936712
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, Wang HP, Kuo SH, Sheu BS, Jan CM, Wang WM, Wang TE, Wu CW, Chen CL, Su IJ, Whang-Peng J, Cheng AL.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1345-53. PubMed ID: 16174856
    [Abstract] [Full Text] [Related]

  • 3. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S, Sano T, Endo H, Kawamata H, Urakami Y.
    J Med Invest; 2000 Feb 21; 47(1-2):36-46. PubMed ID: 10740978
    [Abstract] [Full Text] [Related]

  • 4. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, de Argila CM, Bellas C.
    Haematologica; 2001 Jun 21; 86(6):609-17. PubMed ID: 11418369
    [Abstract] [Full Text] [Related]

  • 5. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
    Kim JS, Chung SJ, Choi YS, Cheon JH, Kim CW, Kim SG, Jung HC, Song IS.
    Br J Cancer; 2007 May 07; 96(9):1324-8. PubMed ID: 17406363
    [Abstract] [Full Text] [Related]

  • 6. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection.
    Akamatsu T, Mochizuki T, Okiyama Y, Matsumoto A, Miyabayashi H, Ota H.
    Helicobacter; 2006 Apr 07; 11(2):86-95. PubMed ID: 16579838
    [Abstract] [Full Text] [Related]

  • 7. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.
    Nakamura S, Matsumoto T, Ye H, Nakamura S, Suekane H, Matsumoto H, Yao T, Tsuneyoshi M, Du MQ, Iida M.
    Cancer; 2006 Dec 15; 107(12):2770-8. PubMed ID: 17099876
    [Abstract] [Full Text] [Related]

  • 8. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study.
    Andriani A, Miedico A, Tedeschi L, Patti C, Di Raimondo F, Leone M, Schinocca L, Romanelli A, Bonanno G, Linea C, Giustini M, Hassan C, Cottone M, Zullo A.
    Dig Liver Dis; 2009 Jul 15; 41(7):467-73. PubMed ID: 18945654
    [Abstract] [Full Text] [Related]

  • 9. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M, Copie-Bergman C, Traulle C, Lavergne-Slove A, Brousse N, Flejou JF, de Mascarel A, Hemery F, Gaulard P, Delchier JC, Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Am J Gastroenterol; 2002 Feb 15; 97(2):292-7. PubMed ID: 11866264
    [Abstract] [Full Text] [Related]

  • 10. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S, Matsumoto T, Suekane H, Nakamura S, Matsumoto H, Esaki M, Yao T, Iida M.
    Cancer; 2005 Aug 01; 104(3):532-40. PubMed ID: 15937928
    [Abstract] [Full Text] [Related]

  • 11. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S.
    Am J Gastroenterol; 2008 Jan 01; 103(1):62-70. PubMed ID: 17894851
    [Abstract] [Full Text] [Related]

  • 12. Lymph node involvement rate in low-grade gastric mucosa-associated lymphoid tissue lymphoma--too high to be neglected.
    Chang DK, Chin YJ, Kim JS, Jung HC, Kim CW, Song IS, Kim CY.
    Hepatogastroenterology; 1999 Jan 01; 46(28):2694-700. PubMed ID: 10522067
    [Abstract] [Full Text] [Related]

  • 13. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G, Martínez Egea A, Sánchez Cuenca J, Onrubia Pintado J, García Lafuente N, Ruiz Gómez F, Coronas Planas M.
    Rev Esp Enferm Dig; 1999 Aug 01; 91(8):541-8. PubMed ID: 10491486
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of disappearance of gastric mucosa-associated lymphoid tissue after anti-Helicobacter pylori therapy.
    Tursi A, Cammarota G, Papa A, Cuoco L, Fedeli G, Gasbarrini G.
    Am J Gastroenterol; 1997 Oct 01; 92(10):1849-52. PubMed ID: 9382050
    [Abstract] [Full Text] [Related]

  • 15. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
    Hong SS, Jung HY, Choi KD, Song HJ, Lee GH, Oh TH, Jo JY, Kim KJ, Byeon JS, Myung SJ, Yang SK, Hong WS, Kim JH, Min YI.
    Helicobacter; 2006 Dec 01; 11(6):569-73. PubMed ID: 17083379
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ, Kim N, Paik JH, Kim JM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC.
    Helicobacter; 2013 Jun 01; 18(3):197-205. PubMed ID: 23305046
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.
    Wündisch T, Thiede C, Morgner A, Dempfle A, Günther A, Liu H, Ye H, Du MQ, Kim TD, Bayerdörffer E, Stolte M, Neubauer A.
    J Clin Oncol; 2005 Nov 01; 23(31):8018-24. PubMed ID: 16204012
    [Abstract] [Full Text] [Related]

  • 18. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis.
    Nakamura S, Aoyagi K, Furuse M, Suekane H, Matsumoto T, Yao T, Sakai Y, Fuchigami T, Yamamoto I, Tsuneyoshi M, Fujishima M.
    Am J Pathol; 1998 May 01; 152(5):1271-9. PubMed ID: 9588895
    [Abstract] [Full Text] [Related]

  • 19. Long-term results of stomach-conserving therapy in gastric MALT lymphoma.
    Vrieling C, de Jong D, Boot H, de Boer JP, Wegman F, Aleman BM.
    Radiother Oncol; 2008 Jun 01; 87(3):405-11. PubMed ID: 18343513
    [Abstract] [Full Text] [Related]

  • 20. Helicobacter pylori induces apoptosis in mucosal lymphocytes in patients with gastritis.
    Reinacher-Schick A, Petrasch S, Burger A, Suerbaum S, Kunstmann E, Schmiegel W.
    Z Gastroenterol; 1998 Dec 01; 36(12):1021-6. PubMed ID: 10025053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.